We investigated mammary gland diferentiation and cela profationin rsafter exposure 'to, men (2) . A recent analysis of chemical plant workers found a more than twofold increase in breast cancer in female workers exposed to dioxin (3), although other studies report negative associations of polychlorinated biphenyls and dioxin with breast cancer (4,5). In one report DDT was associated with a higher risk of developing breast cancer (6), although another study failed to observe a higher risk after DDT exposure (7). DDT, dioxins, polychlorinated biphenyls, and a number of other organochlorine pesticides have been found in breast milk and human adipose tissue (8) . Some (200 p1/rat), on days 25, 27, 29, and 31 postpartum. The doses were derived from the literature which showed these chemicals caused alterations to the endocrine system, reproductive tract, or the liver, or from our unpublished data. We killed the rats 18 hr after the last treatment and removed both abdominal glands-one for preparation of a whole mount and the other for processing as a tissue block for sectioning.
statistically si c effects on cell proliferation and mammary gland development. We conclude that DES, genistein, and sp'. DDT given to pubertal rats act as morphons ie, thy increase cefl an, which promotes mturation ofd th undifferentiated tpe'mnal end buds to more difrentiated lobular terminal ductal structu. Key word: Arodor, cell proliferation, diethylstilbestrol, dioxin, genistein, mammary gland, op' -DDT, xenoestrogens. Environ HealthPert 103: 708-713 (1995) Breast cancer is the most common cancer among females in the United States and is the second leading cause of death among women in this country. In the last decade, the incidence of breast cancer has increased at a rate of approximately 2% per year (1) . Speculation that environmental chemicals, especially estrogenically active chemicals, may be responsible for breast cancer is supported by epidemiological reports. Elevated breast cancer rates have been reported for women exposed to polychlorinated biphenyls in Japan (2) . A recent analysis of chemical plant workers found a more than twofold increase in breast cancer in female workers exposed to dioxin (3) , although other studies report negative associations of polychlorinated biphenyls and dioxin with breast cancer (4, 5) . In one report DDT was associated with a higher risk of developing breast cancer (6) , although another study failed to observe a higher risk after DDT exposure (7) . DDT, dioxins, polychlorinated biphenyls, and a number of other organochlorine pesticides have been found in breast milk and human adipose tissue (8) . Some hormonally active chemicals are synthetic; others occur naturally. We selected six such chemicals to investigate their actions on mammary gland differentiation and cell proliferation. Diethylstilbestrol (DES), genistein, op'-DDT, and Aroclor 1221 are documented to be estrogenically active xenobiotics (9) (10) (11) ; 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) has been reported to be antiestrogenic (12) . Aroclor 1254 is not estrogenic, but it is more toxic in mammalian systems than Aroclor 1221 (11) .
Alterations to mammary gland development and to cellular proliferation from chemical exposure could alter cancer susceptibility. From birth through the first week postpartum in the rat, the mammary gland is composed of a single primary or main lactiferous duct that branches into three to five secondary ducts (13) (14) (15) (13) . We evaluated the outer portion of the entire gland (periphery to 1.78 mm inward).
We measured cell proliferation in the contralateral gland using proliferating cell nuclear antigen (PCNA) as a marker of mitotic activity (20) . Formalin-fixed glands were processed for paraffin embedding within 24 hr of their removal from the animal. We cut 5- 
Results
Pubertal female rats treated with DES for 1 week had reduced body weights as compared to the vehicle-treated females ( Table  1) . The other treatments did not significandy affect body weights. Uterine-ovarian weights were increased after treatment with DES and genistein, decreased by TCDD (Fig. 2) . PCNA staining was not analyzed in the alveolar buds because there were too few of these terminal ductal structures. DES-, genistein-and op'-DDT-treated animals had higher percentages of PCNA-stained cells in all terminal ductal structures than did cells from sesame oil-treated animals (experiment 1). TCDD treatment resulted in decreased PCNA staining in terminal ducts and lobules and no change in terminal end buds (experiment 2). Aroclor 1221 and Aroclor 1254 had slight, but not sta- tistically significant, effects on cell cycling. Figure 3 contains photomicrographs of PCNA-stained terminal end buds from animals treated with sesame oil, genistein, o,p'-DDT, and TCDD. The differences in proliferative indexes are obvious. Analysis of the PCNA staining for Sphase revealed that DES and genistein treatments resulted in a greater percentage of cells from terminal end buds, terminal ducts, and lobules in S-phase (Fig. 4) . op'-DDT caused an increase in S-phase cells in terminal end buds and terminal ducts but not in lobules. TCDD treatment resulted in a decreased percentage of cells in S-phase in terminal ducts only (Fig. 4) . Aroclor 1221 and Aroclor 1254 had no significant effect on PCNA staining for S-phase.
When total cell proliferation in the periphery of an abdominal gland was considered (mean number of terminal ductal structures x mean number of PCNAstained cells per terminal ductal structure), DES-treated females had more PCNAlabeled lobular cells and fewer PCNAlabeled terminal duct cells than the vehicletreated animals (Fig. 5) . Total S-phase cells were increased in terminal end buds and lobules and decreased in terminal ducts of DES-treated animals (Fig. 6) .
Genistein treatment resulted in increased total PCNA-stained terminal end bud and lobular cells (Fig. 5 ) and in Sphase cells (Fig. 6 ). There were no proliferative changes in terminal ducts.
Mammary glands from female rats treated with o,p'-DDT as compared to sesame oil-treated females had increased total PCNA-stained cells in terminal ducts and lobules (Fig. 5 ) and in S-phase cells (Fig. 6) . While the increase of total PCNAstained cells in terminal end buds was not statistically significant, the number of cells in S-phase was increased.
TCDD treatment resulted in fewer total PCNA-stained cells in terminal end buds, terminal ducts, and lobules (Fig. 5) . The mammary glands of the TCDD-treated females also had fewer terminal end bud and terminal duct cells in S-phase, whereas S-phase cell numbers were unchanged in the lobules (Fig. 6) 
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"ITerminal Ducts may be due to a balance between its estrogenic properties and its suppressive effect on growth at these high concentrations. Genistein treatment resulted in significantly increased uterine-ovarian weights, confirming reports of its properties as a weak estrogen (9, 21, 22) . There was also a significant increase in the size of mammary glands from genistein-treated animals. This is consistent with our previous report of early gland maturation in neonates treated with genistein (23) . TCDD treatment resulted in significantly reduced uterine-ovarian weights and mammary gland sizes. This could be a consequence of the antiestrogenic properties of TCDD (12) or extreme toxicity (24) . Treatment with op'-DDT, Aroclor 1221, and Aroclor 1254 had no significant effects on body weights, uterine-ovarian weights, or mammary gland sizes. The slight but not statistically significant changes in these endpoints between experiments I and II may be due to the fact that animals in experiment 2 were slightly older (2 days).
Mammary Gland Development
Since terminal ductal structures of the mammary gland are sensitive to hormonal influence (13, (25) (26) (27) , we investigated the potential of these xenoestrogens to alter gland differentiation. DES treatment reduced the numbers of terminal end buds and terminal ducts and concomitantly increased lobules. This phenomenon appears to be due to accelerated maturation of terminal ductal structures (i.e., progression of terminal end buds and terminal ducts to lobules). Genistein and op'-DDT also appeared to act in a similar manner, even though the progressive changes in terminal ductal structures after treatment with these two compounds were not as profound.
Volume 103, Number 7-8, July-August 1995 L-. Ie --J~ii-15000 jg 13 The overall decrease in numbers of terminal ductal structures and gland size from TCDD treatment may be due to its biological actions on estrogen metabolism (28) and the estrogen receptor (29) , or as a consequence of overt toxicity (24) . Aroclor 1221 and Aroclor 1254 caused slight but not statistically significant effects on the development of terminal ductal structures.
Cell Proliferation
Increased cell proliferation may be a critical factor in chemical carcinogenesis. Russo and Russo (13, 14) and Nagasawa et al. (30) 5) . The large proliferative compartment of terminal end buds can account for the high susceptibility of these undifferentiated structures to carcinogenesis (13, 14, 23) .
DES, genistein, and op'-DDT treatments resulted in increased cellular proliferation in all terminal ductal structures. This is the first report of the phytoestrogen genistein increasing cell proliferation in an in vivo system. In in vitro studies, Makela et al. (31) (23, 33) . However, our data suggest that in vivo genistein acts as a morphogen on the mammary gland. When given before mammary gland maturation was complete and before carcinogen exposure, genistein promoted cell proliferation and hence differentiation of immature terminal end buds, causing them to evolve into mature differentiated structures (i.e., lobules). Lobules are less proliferative and less susceptible to the actions of carcinogens (23) .
Consistent with genistein acting as an estrogen to promote gland maturation and thereby protecting against chemical carcinogenesis (23) are reports that early estrogen treatment also protected against carcinogeninduced mammary tumors (26, 27, 34, 35) . Furthermore, we have observed that neonatal DES treatment protects against spontaneously developing rat mammary tumors (36) . Accordingly, we would expect that o,p'-DDT exposure before mammary gland maturation and before exposure to a genotoxic carcinogen would also protect against mammary tumors. On the other hand, our finding that op'-DDT is a cell proliferator in the mammary gland is consistent with the action of this chemical as a cancer promoter if given after a genotoxic carcinogen (37, 38) .
Although many of the biological actions of TCDD have been associated with the Ah receptor, TCDD can also inhibit a wide range of estrogen-induced responses including cell proliferation in human breast cancer cell lines (28, 39) . Treatment of MCF7 cells with TCDD also caused a decrease in nuclear estrogen receptor levels (29) . TCDD has been shown to suppress estrogen-induced gene transcription, which may lead to cell proliferation (39) (40) (41) 
